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Abstract 
Saliva, the most available and non-invasive biofluid of the human body, permanently “bathes” the oral cavity and 
is trying to cope with an ever-changing milieu. The oral cavity, a very complex and unique milieu due to its dual 
function, is the only place in the body where the mineralized tissue is exposed to the external environment in which 
there are complex interactions between various surfaces: host soft and hard tissues, food, air, and microorganisms. 
Saliva includes a large number of inorganic and organic compounds, which act as a "mirror of the body's health.” In 
addition  to  its  other functions,  saliva  could constitute the first line  of defense against oxidative stress. Due  to  its 
composition and functions, saliva could have a significant role in controlling and/or modulating oxidative damages in 
the oral cavity. As a diagnostic fluid, saliva offers distinctive
 advantages over serum. Furthermore, saliva may
 provide a 
cost-effective  approach  for  the  screening  of  large
  populations.  Gland-specific  saliva  can  be  used  for  diagnosis
  of 
pathology specific to one of the major salivary glands. Whole
 saliva, however, is most frequently used for diagnosis of 
systemic
 diseases.  
As we enter the era of genomic medicine, sialochemistry will play an increasingly important role in the early 
detection,  the  monitoring  and  progression  of  the  systemic  and  oral  diseases.  We  reviewed  the  current  data  within 
literature and of our research concerning clinical potential of the saliva. 
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Introduction 
 
Saliva  is  derived  from  several  types  of 
salivary  glands.  Each  type  of  salivary  gland 
secretes saliva with characteristic composition and 
properties.  The  secretions  from  these  different 
glands have been shown to differ considerably, 
to be complex in composition and to be affected 
by different forms of stimulation, time of day, diet, 
age, gender, a variety of disease states, and several 
pharmacological  agents  [1-4].  Whole  saliva  is  a 
mixed fluid that is derived predominantly from 3 
pairs  of  major  salivary  glands:  the  parotid,  the 
submandibular,  and  the  sublingual  glands. 
Approximately  90%  of  total  salivary  volume 
results from the activity of these 3 pairs of glands, 
with  the  bulk  of  the  remainder  from  minor 
salivary  glands  located  at  various  oral  mucosal 
sites.  The  whole  saliva  also  contains  gingival 
crevicular  fluid  (GCF),  mucosal  transudations, 
expectorated  bronchial  and  nasal  secretions, 
serum  and  blood  derivatives  from  oral  wounds, 
bacteria, and bacterial products, viruses and fungi, 
desquamated  epithelial  cells,  other  cellular 
components, and food debris. 
Serum constituents that are not part of the 
normal  salivary  constituents  (i.e.,  drugs  and 
hormones)  can  reach  saliva  by  several  ways: 
intracellular  (through  passive  transfer,  by 
diffusion) and extracellular (ultrafiltration) [4-6]. Journal of Medicine and Life  Vol. 2, No.2, April-June 2009  
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Serum constituents are also found in whole saliva
 
as  a  result  of  GCF  outflow.  Depending  on  the 
degree of the inflammation
 in the gingiva, GCF is 
either a serum transudation or, more commonly,
 
an  inflammatory  exudation  that  contains  serum 
constituents.
  
Saliva  can  be  collected  with  or  without 
stimulation  [7].
  The
  best  two  ways  to  collect 
whole  saliva  are  the  draining  method,
  in  which 
saliva is allowed to drip off the lower lip, and the
 
spitting method, in which the subject expectorates 
saliva into
 a test tube [8]. 
Let us analyze saliva. 
 
Salivary Composition 
 
Saliva is a clear, slightly acidic (pH 6-7) 
liquid. 
 
Inorganic components 
The most abundant component in saliva is 
water(approximately  99%),  followed  by  ions 
Na
+,Cl
–  Ca
2+,K
+,HCO3
–,H2PO4
–,  F
–,  I
–,Mg
2+, 
thiocyanate.  The  ionic  composition  of  saliva  is 
different from the plasma although derived from 
it. [9]. The hypotonicity facilitates taste sensitivity 
and  hydrates  various  organic  compounds  that 
form  a  protective  coating  on  the  oral  mucosa. 
Resultant bicarbonate serves as a buffering agent 
and  calcium  and  phosphate  neutralize  acids  that 
would  otherwise  compromise  tooth  mineral 
integrity [9, 10]. 
 
Organic components 
Saliva includes a large number of organic 
compounds  such  as:  urea,  ammonia,  uric  acid, 
glucose, cholesterol, fatty acids, mono–, di–, and 
triglycerides,  phosphor  and  neutral  lipids, 
glycolipids,  amino  acids,  steroid  hormones  and 
proteins that aid in the protection of oral cavity 
tissues,  including  mucins,  amylases,  agglutinins, 
glycoproteins, lysozymes, peroxidases, lactoferrin 
and  secretory  IgA.  Non-immune  factors  include 
lactoferrin, lysozyme, myeloperoxidase, histatins, 
cystatins, mucin G1 and G2, and defensins [11-
17].  In  addition,  these  macromolecules  form  a 
viscoelastic  mucosal  coat  and  tooth  enamel 
pellicle  and  aggregate  and  cleanse  bacteria  and 
debris from the oral cavity [18]. Saliva contains a 
variety  of  antimicrobial
  constituents  and  growth 
factors [19,20]. 
There  is  a  strong  relationship  functions-
constituents  of  saliva  and  a  number  of  salivary 
proteins  participate  in  more  than  one  function. 
Function of saliva are: digestion, mastication and 
deglutition,  protective  (antifungal,  antibacterial, 
antiviral  activity,  lubricant  and  buffering  agent), 
defense  (spiting  and  oxidative  stress)  ,drug 
testing,  water  balance,  excretion,  speaking, 
denture  retention,  tasting,  chemical 
communication  (kissing    or  infant  salivating 
represents a lovable sight to a parent) [2,3,21-23]. 
It is probably surprising for most people to learn 
that saliva has been used in diagnostics for more 
than  two  thousand  years.  Ancient  doctors  of 
traditional Chinese medicine have concluded that 
saliva  and  blood  are  ‘brothers’  in  the  body  and 
they come from the same origin. It is believed that 
changes in saliva are indicative of the wellness of 
the patient. 
Saliva offers some distinctive advantages 
[1,22,24-26]:  smaller  sample  aliquots,  the 
possibility of a dynamic study, greater sensitivity, 
non-  invasive,  stress  free  and  easy  collection 
procedure, a good cooperation with patients, the 
possibility  to  collection  somewhere  and 
anywhere, no special equipment and not a trained 
technician  are  needed  for  collection,  correlation 
with  levels  in  blood,  potentially
  valuable  for 
children  and  older  adults,  more  accurate  than 
blood  for  detection  of  many  oral  and  systemic 
diseases,  may
  provide  a  cost-effective  approach 
for  the  screening  of  large
  populations,  could 
eliminate  the  potential  risk  of  contracting 
infectious  disease  for  both  a  technician  and  the 
patient.   
Advances  in  the  use  of  saliva  as  a 
diagnostic  fluid  have  been  affected  by  current 
technological  developments:  enzyme-linked 
fluorescence  technique,  Western  blot  assays, 
polymerase chain reaction (PCR). 
 
Systemic Diseases 
Salivary  gland  and  the  composition  of 
saliva are affected directly or indirectly
 and these 
changes may contribute to the diagnosis and early 
detection of these
 diseases.
  
The abnormal secretions present in cystic 
fibrosis  CF  caused  clinicians  to  explore
  the 
usefulness  of  saliva  for  the  diagnosis  of  the 
disease. Most
 studies agree that the saliva of CF 
patients contains increased
 calcium (resulted
 in a 
calcium-protein  aggregation  which  caused 
turbidity of saliva and phosphate levels that could 
explain  a  higher  occurrence  of
  calculus,  more 
neutral lipids, phospholipids and glycolipids, as a 
consequence  for  the  altered  physico-chemical 
properties
 of saliva in this disease, elevations in 
urea,  uric  acid,
  and  total  protein,  especially  in 
submandibular  saliva  [27-33].  Saliva  from  CF 
patients was found to
 contain an unusual form of 
epidermal  growth  factor  (EGF  and  abnormally Journal of Medicine and Life  Vol. 2, No.2, April-June 2009  
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elevated  levels  of  prostaglandins
  E2  (PGE2) 
[33,34].  Early  morning  salivary  levels
  of  17-
hydroxyprogesterone (17-OHP) were reported to 
be an excellent
 screening test for the diagnosis of 
non-classic 21-hydroxylase
 deficiency [35]. 
Sjögren's  syndrome  (SS),  an 
autoimmune exocrinopathy
 of unknown etiology, 
a reduction in lachrymal and salivary
 secretions is 
observed,  associated  with  keratoconjunctivitis
 
sicca and xerostomia.
 Sialochemistry may also be 
used  to  assist  in  the  diagnosis  of
  SS:  increased 
concentrations  of  sodium
  and  chloride,  elevated 
levels
  of  IgA,  IgG,  lactoferrin,  albumin, 
inflammatory mediators—i.e.,
 eicosanoids, PGE2, 
thromboxane  B2,  and  interleukin-6—have
  been 
reported,  and  a  decreased  concentration
  of 
phosphate.  Reduced  salivary  flow  is  of  clinical 
importance and can lead to a variety
 of oral signs 
and symptoms, such as progressive dental caries,
 
fungal  infections,  oral  pain,  and  dysphagia.
 
Dentists are normally the first to encounter these 
patients [36-42]. 
Salivary  analysis  is  more  accurate  than 
blood for detection of cancer. 
It  is  well  known  that  for  most  cancers, 
successful  treatment  depends  on  early  detection 
and successful prevention depends on the accurate 
evaluation  of  risk.  One  of  the  most  important 
missions  of  the  medicine  is  to  translate  newly 
emerging  molecular  knowledge  into  practical 
clinical tests to detect cancer and cancer risk [24-
26,43]. 
p53 is a tumor suppressor protein which is
 
produced  in  cells  exposed  to  various  types  of 
DNA-damaging  stress.
  Inactivation  of  this 
suppressor through mutations and gene deletion
 is 
considered  a  frequent  occurrence  in  the 
development of human
 cancer. The
 p53 antibodies 
can be detected in sera of patients with different
 
types  of  malignancies  in  the  saliva  of  patients 
diagnosed  with  oral  squamous  cell  carcinoma 
(SCC) [44-48]. 
Elevated  levels  of  salivary  defensins, 
peptides that possess antimicrobial and cytotoxic 
properties  founded  in  the  azurophil  granules  of 
polymorphonuclear
  leukocytes  (PMNs)  were 
detected in patients with oral SCC [49-51]. 
Many  studies  indicate  that  there  exist 
differences  in  patterns  of  mRNA  expression  in 
saliva  that  would  indicate  the  presence  of  a 
developing SCC. Salivary mRNA may serve as a 
chemical signature that a particular gene has been 
expressed. Aberrant gene promoter methylation of 
DNA derived from exfoliated oral mucosal cells 
sampled from whole saliva has also been reported 
suggesting  that  this  may  form  the  basis  of  a 
screening  test  [24].  This  has  proven  useful  for 
both  biomarker  profiling  and  forensic 
identification. 
Elevated  levels  of  recognized
  tumor 
markers  c-erbB-2  (erb)  and  cancer  antigen  15-3 
(CA15-3)
  were  found  in  the  saliva  of  women 
diagnosed  with  breast  carcinoma,
  as  compared 
with  patients  with  benign  lesions  and  healthy 
controls and thus appears to hold greater promise
 
for  the  early  screening  and  detection  of  breast 
cancer.
 CA 125 is a tumor marker for epithelial 
ovarian cancer. Elevated
 salivary levels of CA 125 
were  detected  in  patients  with  epithelial
  ovarian 
cancer [52,53]. 
In  cardiovascular  diseases,  a  major 
cause  of  death  world-wide,  if  salivary  amylase 
levels  were  low  in  postoperative  patients  with 
ruptured aortic aneurysm, there was an associated 
increase in mortality, Therefore, salivary amylase 
appears to be a more direct and simple end point 
of  catecholamine  activity  than  changes  in  heart 
rate when evaluating patients under a variety of 
stressful conditions [1,25,26]. 
Saliva  can  be  analyzed  as  part  of  the 
evaluation  of  endocrine
  function  [54]. 
Measurements of salivary  hormone levels
 are of 
clinical importance if they accurately reflect the 
serum
 hormone levels or if a constant correlation 
exists between
 salivary and serum hormone levels 
[1,24,25]. Monitoring salivary
 testosterone levels 
may  also  be  useful  in  behavioral  studies
  of 
aggression,  depression,  abuse,  and  violent  and 
antisocial
 behavior [55-57]. 
Saliva levels of steroid hormones reflect 
the free, and thus active, level of these hormones 
(while most blood measurements reflect the total 
level).  Currently,  the  following  steroids  can  be 
accurately assessed in saliva: aldosterone, insulin, 
cortisol,  dehydroepiandrosterone,  estradiol, 
estriol, progesterone and testosterone. 
 
Infectious diseases. 
1.  Viral  diseases.  Saliva  is  superior  to 
serum and urine to both sensitivity and specificity 
in testing for HIV infection, human herpes virus, 
cytomegalovirus,  Epstein-Barr  virus,  hepatitis  C 
virus [1,2,24,25]. The basis for many diagnostic
 
tests  in  virology  is  the  antibody  response  to 
infection.  Saliva  contains  immunoglobulins  (Ig) 
that  originate
  from  two  sources:  the  salivary 
glands and serum. The predominant
 Ig in saliva is 
secretory  IgA  (sIgA),  which  is  derived
  from 
plasma cells in the salivary glands, and constitutes 
the
 main specific immune defense mechanism in 
saliva [58-60]. In contrast, salivary IgM and IgG
 
are primarily derived from serum  via GCF,  and 
are present in
 lower concentrations in saliva than 
is  IgA.  Antibodies  against
  viruses  and  viral 
components can be detected in saliva and can
 aid Journal of Medicine and Life  Vol. 2, No.2, April-June 2009  
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in  the  diagnosis  of  acute  viral  infections, 
congenital  infections,
  and  reactivation  of 
infection.
  Saliva  was  found  to  be  a  useful 
alternative  to  serum  for  the
  diagnosis  of  viral 
hepatitis, acute hepatitis A (HAV), B (HBV) [61-
68].  
For  newborn  infants,  the  salivary  IgA 
response  was  found  to
  be  a  better  marker  of 
rotavirus (RV) infection than the serum
 antibody 
response and can be used to monitor the immune
 
response  to  vaccination  and  infection  with  RV 
[69].  
Salivary
  IgA  levels  to  HIV  decline  as 
infected  patients  become  symptomatic.
  It  was 
suggested that detection of IgA antibody to HIV 
in  saliva
  might,  therefore,  be  a  prognostic 
indicator for the progression
 of HIV infection. In 
conclusion, collection and analysis
 of saliva offer 
a simple, safe, well-tolerated, and accurate
 method 
for  the  diagnosis  of  HIV  infection.  The  non-
invasive  nature  in  which  a  sample  is  collected 
eliminates  the  risk  of  infection  inherent  in 
collecting blood samples [70-74]. 
 
2.  Bacterial  infections.  Saliva  is  very 
useful  for  (diagnosis  of  Helicobacter  pylori 
(associated  with  peptic  ulcer),  the  detection  of 
dental plaque-induced diseases, i.e. dental caries, 
gingivitis,  periodontal  disease  [75-81].  In 
principle,  this  application  of  saliva-based 
diagnostics appears to be feasible! 
Detection,  measurement,  and 
monitoring of drugs 
Many analyses, including drugs of abuse, 
can  be  measured  in  saliva  and  oral  fluids. 
Particularly  useful  where  a  “yes/no”  answer  is 
required, oral fluid based tests find wide usage in 
detection of recreational drugs, including alcohol, 
amphetamines,  barbiturates,  benzodiazepines, 
cocaine,  a  variety  of  inhalants,  lysergic  acid 
diethylamide  (LSD),  marijuana,  opioids, 
phencyclidine  (PCP),  and  tobacco.  The  use  of 
saliva for drug monitoring, and the detection of 
illicit  drugs,  has  grown  remarkably.  currently, 
saliva  can  be  used  to  detect  and/or  monitor 
nicotine,  cannabinoids,  cocaine,  phencyclidine, 
opioids,  barbiturates,  diazepines,  amphetamines 
and  ethanol  (most  recently,  law  enforcement 
agencies  have  employed  saliva-based  tests  for 
roadside  evaluation  of  alcohol  levels  and  in 
hospital emergency departments as a rapid means 
of determining whether impaired consciousness is 
related to alcohol intoxication) [24,26,82-84]. 
 
Again and again about tobacco! 
Tobacco usage or exposure (via “passive” 
or  “second-hand”  smoke)  is  now  routinely 
measured  by  quantization  of  levels  of  salivary 
nicotine  that  are  similar  clearance  and  half-life 
values  as  plasma.  Monitoring  levels  of  salivary 
nicotine  has  proven  useful  in  monitoring  self-
reported  compliance  with  smoking  cessation 
programs. Salivary
 nicotine levels were found to 
be indicative of active and passive
 smoking [84-
85]. Salivary
 thiocyanate was also found to be an 
indicator  of  cigarette  smoking
  [86];  however, 
nicotine  levels  are  considered
  the  most  reliable 
marker [87].An adequate intake may help smokers 
to  avoid  cigarette  smoke  induced  oxidative 
damage and to prevent degenerative disease. The 
smoking causes the decrease in salivary important 
antioxidants  levels  and  the  loss  of  activity  of 
salivary enzymes with antioxidant actions  can be 
considered  as  one  of  the  mechanisms  by  which 
the toxic effects of CS initiate oral inflammatory 
diseases,  promote  precancerous  transformations 
and destroy the oral cavity homeostasis [88-90]. 
 
Oral Diseases  
Evaluation of the quantity of whole saliva
 
is simple and may provide information, which has 
systemic  relevance  [91].
  Quantitative  alterations 
in saliva may be a result of medications (at least 
400  drugs  may  induce  xerostomia.  Diuretics, 
antihypertensives,
  antipsychotics,  antihistamines, 
antidepressants,  anticholinergics,
  antineoplastics, 
amphetamines,
  barbiturates,  hallucinogens, 
cannabis, and alcohol have been
 associated with a 
reduction in  salivary  flow  and  may  lead  to  oral 
problems
  like  progressive  dental  caries,  fungal 
infection, oral pain,
 and dysphagia [92,93]. 
Qualitative  changes  in  salivary 
composition  can  also  provide
  diagnostic 
information  concerning  oral  problems:  increased 
levels
 of albumin in whole saliva were detected in 
patients who received
 chemotherapy as treatment 
for cancer and subsequently developed
 stomatitis, 
reduced
 salivary EGF levels may be important for 
the  progression  of
  radiation-induced  mucositis, 
higher  levels  of  salivary  nitrate  and  nitrite,  and 
increased
 activity of nitrate reductase, were found 
in  oral  cancer  patients
  compared  with  healthy 
individuals, and were associated with
 an increased 
odds ratio for the risk of oral cancer [94-96].  
Saliva  is  also  very  suitable  for  the 
monitoring
  of  oral  bacteria  that  can
  survive  in 
saliva,  and  can  utilize  salivary  constituents  as
  a 
growth medium, for example, increased numbers 
of Streptococcus mutans and Lactobacilli in
 saliva 
were associated with increased caries prevalence 
and with the presence
 of root caries, detection
 of 
certain bacterial species in saliva can reflect their 
presence
 in dental plaque and periodontal pockets 
[97-103]. The changes of the components of the 
saliva may also be used for periodontal
 diagnosis 
[104-106]. Recent studies focus on the potential Journal of Medicine and Life  Vol. 2, No.2, April-June 2009  
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role  of  periodontal  disease
  as  a  risk  factor  for 
cardiovascular  and  cerebrovascular  diseases
  as  a 
possible  link  with  metabolic  syndrome  and 
oxidative stress [107-111]. 
Uric acid levels are significantly lower in 
saliva  from  heavy  smokers,  oral  cancer, 
periodontitis  and  diabetic  patients  with 
periodontitis, giving emphasis of oxidative stress 
in  oral  cavity.  A  lower  level  of  saliva  albumin 
was  found  in  periodontal  disease  and  diabetic 
patients,  probably  due  to  oxidative  stress  in  the 
oral cavity. 
Total  antioxidant  capacity  (TAC)  is 
significantly  lower  in  periodontal  disease, 
diabetics,  smokers,  and  oral  cancer.  When 
exposed to cigarette smoke, saliva loses its TAC 
and becomes a potent prooxidant milieu. 
Salivary peroxidase is lower in smokers, 
most probably due to the cyanide ions present in 
cigarette smoke, a very powerful inhibitor of hem 
peroxidase and in saliva from patients with oral 
cancer.  The  results  indicate  that  exposure  to 
cigarette  smoke  (CS)  caused  a  statistically 
significant  decrease  of  salivary  gamma-
glutamyltransferase  (GGT)  caused  by  the 
oxidative  stress.  Salivary  aspartate 
aminotransferase  (AST),  alanine 
aminotransferase  (ALT)  and  alkaline 
phosphatase  (ALP)  are  markers  in 
periodontitis [21,111]. 
In  Alzheimer  disease  (AD)-Salivary 
AChE activity may prove to be a useful marker of 
AD-associated  changes  in  central  cholinergic 
activity  and  the  responsiveness  of  patients  to 
treatment with AChE inhibitors [1]. 
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